Takashina, S
GLP-1RAs may be the drugs of choice for the treatment of diabetes because of their cardioprotective, neuroprotective and renal protective activities other than lowering blood glucose, while not causing side effects of hypoglycemia and weight gain, with a proven efficacy and safety (Sharma et al., 2018
Under the Medicare GLP-1 Bridge program, eligible participants enrolled in a Medicare Part D prescription drug plan or a Medicare Advantage plan that includes prescription drug coverage will have access to certain GLP-1 medications for $50 per month from July 1, 2026, through Dec
Taking ibuprofen on an empty stomach might increase risks
If fat loss stalls despite maintained caloric deficit, the issue is rarely dosage insufficiency
Stay alert for dizziness, extreme fatigue, or heart palpitationsthese signal electrolyte imbalances requiring medical attention